A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
Clinical trial NCT07301333 · RECRUITING
Trial details
- NCT number
- NCT07301333
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2026-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.